<DOC>
	<DOCNO>NCT00901043</DOCNO>
	<brief_summary>The purpose study examine effect sustain walnut consumption endothelial function lipid marker patient Type 2 diabetes mellitus .</brief_summary>
	<brief_title>Effects Walnut Consumption Endothelial Function Type 2 Diabetes</brief_title>
	<detailed_description>Evidence-based guideline management type 2 diabetes mellitus relate cardiovascular disease ( CVD ) refer cardioprotective dietary fatty acid proportion . Several study demonstrate hypocholesteremic effect walnuts energy restrict diet . To knowledge , health benefit accrue result addition walnut ad libitum diet type 2 diabetic subject study . Addition walnuts ad libitum diet represent practical way achieve recommend fatty acid proportion . The propose study examine whether total dietary pattern inclusive walnut , result amelioration cardiac risk measure improvement endothelial function glycemic control type 2 diabetic . Results study important implication clinician dietitian dietary management type 2 diabetes . Demonstrating walnut regard beneficial component dietary management type 2 diabetes relevance walnut industry well . The study employ pragmatic approach approximate dietary practice real world set thus enhance external validity study . If positive , study result inform future marketing effort California Walnut Commission . Demonstrating addition walnut ad libitum diet potentially lead improvement endothelial function , improve lipid profile , glycemic control reduce risk CVD complication diabetic patient important application dietary management diabetes .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>1. men woman age 3575 2. nonsmoker 3. able blood pressure take bilaterally 4. diagnose type 2 diabetes physician least one year 5. stable glucose level medication dose past 3 month 6. insulin therapy 1. failure meet inclusion criterion 2. anticipated inability complete comply study protocol reason ( e.g. , inability communicate English , dementia ) unstable medical condition would limit ability subject participate fully trial ( e.g. , waste illness , AIDS , tuberculosis , psychotic disorder ) 3. diagnose eat disorder 4. use lipidlowering antihypertensive medication ( statin , red rice yeast extract , garlic ) unless stable medication least 3 month willing refrain take medication 12 hour prior endothelial function ( EF ) scanning , vasoactive medication ( i.e. , glucocorticoid , antineoplastic agent , psychoactive agent , bronchodilator ) nutriceuticals 5. regular use multivitamin and/or complementary alternative supplement therapy unwillingness discontinue supplementation least 8 week prior study initiation study duration 6. rheumatologic disease require regular use nonsteroidal antiinflammatory drug ( NSAIDs ) alternative medication 7. regular use fiber supplement 8. preexist cardiovascular disease , include symptomatic coronary artery disease ( CAD ) , myocardial infarction , angina pectoris , anginal equivalent , peripheral vascular disease ( claudication , amputation , revascularization ) congestive heart failure , carotid stenosis , aortic stenosis stroke ; diabetes , sleep apnea , severe uncontrolled hypertension ( systolic blood pressure &gt; 180 mmHg diastolic blood pressure &gt; 105 mmHg ) 9. coagulopathy , know bleed diathesis history clinically significant hemorrhage ; current use warfarin 10. clinically significant anemia ( Hct &lt; 36 % men , &lt; 33 % woman ) 11. intestinal stomach disease 12. inability use right leave arm endothelial function test reason breast surgery , trauma , radiation right axilla , lymphedema , right arm shunt , severe vascular disease right arm 13. subject disease specific diet 14. subject weight control diet 15. subject vegan diet 16. allergy kind nut , include walnut peanut</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>